Why ECG testing for COVID-19 patients is an essential tool for primary care providers

Published on
March 4, 2022

Recent studies found a high percentage of COVID-19 patients develop cardiac related complications that can be detected early on with ECG tests. Most patients have no symptoms (read more here). 


What studies found so far:

 

1. QRS and QTc intervals are early markers for COVID-19 disease progression and mortality. ECG, a readily accessible tool, identifies cardiac involvement and may be used to predict disease course. Lancet, read more here (link).

2. Repolarization abnormalities represented the most common findings (40%), with negative T waves representing 21% of all abnormalities. Read the study here (link).

3. In the largest cohort of COVID-19 patients with complete ECG data on presentation, ..., QTc >500 ms is an independent risk factor for in-hospital mortality. Read the study here (link).

4. This systematic review suggests that identifying ECG patterns that might be related to COVID-19 is vital. Read the study here (link).


ECG testing is rather a standard daily work for the many cardiologists in our healthcare systems. But the recent findings suggest perhaps a wider ECG testing would benefit patients, especially those with high blood pressure or other pre-existing conditions.


That’s why Lara Health had launched a white-glove service for primary care providers interested in a hassle free ECG monitoring and reporting. For more information on Lara Health ECG offering, please schedule a quick call back here: schedule demo link


Weekly newsletter
No spam. Just the latest releases and tips, interesting articles, and exclusive interviews in your inbox every week.
Read about our privacy policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Lara Health is a practice-first, patient-centric care platform

Designed for health providers with big goals. Trusted by clinicians, loved by patients, empowering to all